Norris Medicines Limited (BOM:524414)

Norris Medicines Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 4, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	137	134	168	136	105	350
Market Cap Growth	-18.91%	-20.44%	23.38%	30.14%	-70.10%	437.69%
Enterprise Value	352	348	383	351	319	550
Last Close Price	13.72	13.35	16.78	13.60	10.45	34.95

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 4, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PS Ratio	1.81	1.64	2.88	2.41	1.25	3.70
PB Ratio	-0.91	-0.88	-1.13	-1.00	-0.84	-3.27
P/FCF Ratio	24.16	23.51	34.17	80.65	8.94	-
P/OCF Ratio	23.76	23.11	32.90	80.11	8.71	-

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 4, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	4.64	4.27	6.59	6.23	3.82	5.83
EV/EBITDA Ratio	67.15	48.94	-	-	34.52	-
EV/EBIT Ratio	-	158.42	-	-	108.08	-
EV/FCF Ratio	62.03	61.19	78.09	208.24	27.30	-

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 4, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	-1.42	-1.42	-1.45	-1.58	-1.72	-1.97
Debt / EBITDA Ratio	41.04	30.32	-	-	23.13	-
Debt / FCF Ratio	-	37.91	43.95	127.63	18.30	-
Net Debt / Equity Ratio	-1.42	-1.42	-1.45	-1.58	-1.72	-1.97
Net Debt / EBITDA Ratio	41.00	30.29	-97.40	-120.43	23.11	-334.03
Net Debt / FCF Ratio	-	37.88	43.87	127.41	18.28	-19.78
Asset Turnover	-	0.61	0.42	0.40	0.60	0.56
Inventory Turnover	-	1.06	0.83	0.72	1.25	1.48
Quick Ratio	-	0.13	0.14	0.12	0.14	0.16
Current Ratio	-	0.61	0.63	0.67	0.64	0.63
Return on Assets (ROA)	-	1.03%	-3.38%	-3.36%	1.32%	-2.65%
Return on Capital Employed (ROCE)	-	6.50%	-20.70%	-15.10%	4.90%	-9.70%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 4, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	-2.67%	-2.10%	-7.37%	-8.72%	-16.74%	-9.34%
FCF Yield	4.14%	4.25%	2.93%	1.24%	11.19%	-3.05%
Buyback Yield / Dilution	0.10%	-0.21%	-	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 4, 2026

Data Sources Report a data error